Jeroen Hendrikus Jacobus Paulissen

4PUBLICATIONS
10CO-AUTHORS
Economic models and forecastingModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 20, 2025
A review of methodological aspects of economic evaluations used in NICE assessments for treatments in metastatic breast cancer.

Jeroen Hendrikus Jacobus Paulissen, Sharon Wolters, Arjan Jacobus Postma

|Nov 12, 2024
Cost-Effectiveness of Trastuzumab Deruxtecan in Patients with Unresectable or Metastatic HER2-Low Breast Cancer Who Have Received Prior Chemotherapy.

Jeroen Hendrikus Jacobus Paulissen, Alexander Victor van Schoonhoven, Emma Olin

|Jul 24, 2023
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland.

Jeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton

|Mar 11, 2023
Costs of radium-223 and the pharmacy preparation 177Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals.

S W Quist, J H J Paulissen, D N J Wyndaele

Pageof 1

Frequent Collaborators

3 joint publications

Roel Donald Freriks

3 joint publications

Marinus van Hulst

3 joint publications

Maarten Jacobus Postma

1 joint publications

S W Quist